
|Articles|June 1, 2004
'Repair mutation' identified in case of EBS
Dundee, Scotland - A routine cell culture of a patient with epidermolysis bullosa simplex (EBS) has led to the inadvertent discovery of a revertant mutation that deactivates the original pathogenic mutation, according to Irwin McLean, Ph.D.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Addressing Delays in Prior Authorization Processes That Negatively Impact Patients
2
Meta-analysis Confirms Benefits of Roflumilast 0.3% Cream for PsO
3
Transformative Advances This Year and Beyond
4
Emerging Topical Alternatives to Hydroquinone in Melasma Management
5


















